Pharmacy Times February 9, 2025
Molly Schiffer, PharmD, BCOP, discusses the logistical and operational challenges of delivering outpatient CAR T-cell therapy, emphasizing the benefits of outpatient treatment, including reduced costs, improved access to therapy, and better quality of life for patients.
Pharmacy Times® interviewed Molly Schiffer, PharmD, BCOP, stem cell transplant and cellular therapy clinical pharmacy specialist at Yale New Haven Hospital in Connecticut, on her presentation on the logistical and operational challenges of delivering cellular therapies in the outpatient setting at the 2025 American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) Tandem Meeting in Honolulu, Hawaii.
During the interview, Schiffer emphasized the benefits of outpatient chimeric antigen receptor (CAR) T-cell therapy treatment, including reduced...
Today's Sponsors
Today's Sponsor